# Ciprofloxacin

NDC: 68788-8200
Generic name: Ciprofloxacin
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20220524

FDA application: ANDA208921

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-8200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-8200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18414c5a-8153-44f7-b27a-90c290af0a23